ENTG:NASDAQEntegris, Inc. Analysis
Data as of 2026-03-31 - not real-time
$116.43
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Entegris is trading at $116.43, just above its 20‑day SMA ($116.14) but still below the 50‑day SMA ($121.76), indicating a short‑term price edge that has not yet broken higher trends. The RSI sits at 48, well within the neutral zone, while the MACD line remains beneath its signal line, producing a bearish signal that aligns with the observed decreasing volume trend. A 30‑day volatility of nearly 60% and a computed beta of 2.47 highlight the stock’s heightened sensitivity to market swings, reinforcing a risk‑on profile despite a neutral overall trend.
Fundamentally, the stock appears significantly overvalued with a trailing P/E of 75 versus an industry average of 32, though the forward P/E of 26.6 suggests earnings are expected to improve. The discounted cash‑flow model pins a fair value near $5, implying a 21% upside on a relative basis, but the stark contrast with the current price points to a valuation disconnect. Dividend yield is modest at 0.37% with a payout ratio under 30%, supporting dividend sustainability, yet the balance sheet bears a high debt‑to‑equity ratio of 96% and total debt of $3.8 B, raising leverage concerns. Recent headlines about a potential $4 trillion government consortium to fund semiconductor supply chains could provide a tailwind for demand, but analysts remain cautious, noting limited direct AI exposure and a 50% YTD rally that may have already priced in much of the upside.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Bearish MACD and decreasing volume
- Current price still above immediate support
- High short‑term volatility and beta
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Forward P/E suggests earnings improvement
- Potential demand boost from government semiconductor funding
- Elevated leverage and overvaluation caution
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Secular growth in semiconductor materials and purity solutions
- Sustainable dividend with low payout ratio
- Long‑run valuation correction potential
Key Metrics & Analysis
Financial Health
Revenue Growth-3.00%
Profit Margin7.37%
P/E Ratio75.1
ROE6.16%
ROA3.62%
Debt/Equity96.42
P/B Ratio4.5
Op. Cash Flow$695.4M
Free Cash Flow$317.8M
Industry P/E32.4
Technical Analysis
TrendNeutral
RSI48.4
Support$107.25
Resistance$129.96
MA 20$116.14
MA 50$121.76
MA 200$95.42
MACDBearish
VolumeDecreasing
Fear & Greed Index74.36
Valuation
Fair Value$5.00
Target Price$141.40
Upside/Downside21.45%
GradeOvervalued
TypeBlend
Dividend Yield0.37%
Risk Assessment
Beta2.47
Volatility59.60%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.